TCR² Therapeutics Announces Pricing of Public Offering of $140.0 Million of Common Stock
CAMBRIDGE, Mass., Jan. 19, 2021 (GLOBE NEWSWIRE) TCR
2 Therapeutics Inc. (Nasdaq: TCRR) (“TCR
2” or the “Company”), a clinical-stage immunotherapy company with a pipeline of novel T cell therapies for patients suffering from cancer, today announced the pricing of an underwritten public offering of 4,590,164 shares of its common stock at a public offering price of $30.50 per share. TCR
2 also granted the underwriters a 30-day option to purchase up to an additional 688,524 shares of common stock at the public offering price, less the underwriting discounts and commissions. The gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses payable by the Company, are expected to be approximately $140.0 million, excluding any exercise of the underwriters’ option to purchase additional shares. All of the shares in the offering are to be
Share this article
Share this article
RYE, N.Y., Jan. 20, 2021 /PRNewswire/ Authentic Equity Acquisition Corp. (the Company ), a special purpose acquisition company formed for the purpose of entering into a combination with one or more businesses, today announced that it closed its initial public offering of 20,000,000 units at $10.00 per unit and the sale of an additional 3,000,000 units at a price of $10.00 per unit pursuant to the underwriters full exercise of their over-allotment option. Total gross proceeds from the offering were $230,000,000, before deducting underwriting discounts and commissions and other expenses. Each unit consists of one Class A ordinary share of the Company and one-half of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share of the Company at a price of $11.50 per share. The units are listed on the Nasdaq Capital Market and trade under the ticker symbol AEACU. Once the securities comprising
/PRNewswire/ Commercial Metals Company (NYSE: CMC) ("CMC") announced today a proposed offering (the "Notes Offering") of $300 million in aggregate principal.
/PRNewswire/ Commercial Metals Company (NYSE: CMC) ("CMC") announced today that it has agreed to sell $300.0 million aggregate principal amount of 3.875%.
Share this article
Share this article
NEW YORK, Jan. 14, 2021 /PRNewswire/ Edify Acquisition Corp. (the Company ) announced today the pricing of its upsized initial public offering ( IPO ) of 24,000,000 units at a price of $10.00 per unit. The Company is a special-purpose acquisition company with a focus on the education, education technology, workforce development, and human capital management industries.
Former Vice Chairwoman of BMO Capital Markets Susan Wolford serves as Chairwoman and Colbeck Capital Management, LLC Partner and Managing Director Peter Ma serves as Chief Executive Officer. Wolford and Ma are joined by board members including Rose Else-Mitchell (President of Education Solutions at Scholastic) and Ronald Schlosser (former Executive Chairman at McGraw-Hill Education).